Learn more about the findings Sonnenburg will share in his keynote, and find out more about developing areas of microbiome research that have influenced his work.
Matthew Stanton, CSO of Generation Bio, previews what he'll discuss at the conference and also shares thoughts on CRISPR trends and what's on the horizon.
Learn about how DNA printers work and how they are poised to revolutionize synthetic biology.
A special section looks at how fermentation could boost sustainability in the chemical industry, how microbes are the next great domestication challenge, and offers an exploration of the microbiome as medicine.
Stepping into the role as interim editor-in-chief is Elizabeth Nance, Jagjeet and Janice Bindra Endowed Career Development Associate Professor of Chemical Engineering and Chemical Engineering Associate Chair for Undergraduate Studies at the University of Washington.
This month, there's an Engage conversation about personal finance tips, while others are sharing accounts of accident incidents, or looking for fellow students interested in biomedical topics.
Meet Ronke Olabisi of UC Irvine and learn how she left aerospace engineering to join the world of biomedical engineering, and hear what areas of study she finds most interesting.
This short video provides teachers with a way to introduce school students to CRISPR-Cas9. Also see the accompanying downloadable lesson plan.
Sytems that interact with cell and tissue barriers in the body are being developed to improve therapeutic delivery and promote healing.
Optogenetics is opening new doors, thanks to discoveries about how neurons function and their role in various conditions and behaviors.
Ed discusses his work in optogenetics and neurology, including challenges he faces and his insights into the future of the field.
AIChE and the AIChE Foundation unveil a fellowship program to assist researchers in pursuing innovative technical work with the potential to make valuable contributions to society.
Caltech's Mikhail Shapiro discusses his work in cell-based medicine and highlights top trends in biomedicine.
Suddenly, synthetic biology is being discussed a lot beyond the walls of academia and the pages of scientific journals. Today, it abounds in the mainstream press.
Understanding the bivalve genome and the mechanisms of how they fight disease could lead to new drugs, therapies, and novel biomaterials.
The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.
Students have a unique opportunity to hear from major leaders in the fast-growing and interdisciplinary world of regenerative engineering.
The article “A Novel Mammalian Cell Line Development Platform Utilizing Nanofluidics and OptoElectro Positioning Technology” is drawing tremendous attention.
Humans have roughly 40 trillion bacterial cells in their bodies; up to 1,000 species of bacteria live in the human gut alone.
Looking for a promising career direction? Biotech is a vast and diverse field and has growing opportunities.
This month, brush up on the essentials of continuous evaporation, learn new uses for hydrofoil impellers, enjoy the special section on translational medicine, and more.
Because synthetic biology can tackle specific mammalian cell behavior, it can be used to enable therapies that are specific to a patient.
Epigenetics — the study of how our actions and experiences mark or modify our DNA — can explain some unusual genetic findings.
Researchers use an ultrasound system to trigger responses in T cells, causing them to attack cancer cells.
An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.
Researchers have reversed disease in mice using a CRISPR-Cas9 technique that alters gene activity rather than the underlying sequence.
The new technique has successfully altered 80% of targeted genes, the highest rate ever achieved in an adult animal.
Chemical engineers' response to the addiction epidemic, cogeneration operation basics, an overview of Colombia's chemical industry, and more.
Researchers at the University of Nebraska-Lincoln have uncovered clues about how the Zika virus became much more dangerous in recent years.
Hear about some of the upcoming highlights at the Bioengineering & Translational Medicine Conference from Juergen Hahn, professor of biomedical engineering at Rensselaer.
Microscopic versions of silkworm cocoons that could be used to protect sensitive molecular materials.
The failure rate for new drugs and therapies under development exceeds 95%.
New technique seeks to eliminate latent reservoirs of the virus in the body.
Biomedical engineers at Duke University have devised an improved method for detecting the signs of cancer in a single cell using lasers and a camera.
A compound found in a snail's venom yields pain-fighting effects in testing, presenting a possible opioid alternative.
Researchers at Indiana University Bloomington have discovered that a molecule related to some forms of cancer and neurodegenerative disorders is also present in developing Drosophila
Researchers at Spain's Carlos III University of Madrid unveiled a 3D bioprinter prototype that creates fully functional human skin.
As we approach ICBE 2017, which begins this weekend in San Diego, we look back at some of the exciting research that figured among 2016's highlights and look forward to the new developments to be unveiled at ICBE 2017.
Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.
This special issue focuses on smart and precision medications, presenting novel work aimed at a wide range of medical applications, from diabetes treatments, cancer therapy, tissue engineering, drug delivery, and more.
Researchers at the University of California, Riverside, recently published work that suggests that the usefulness of studying pro- and anti-apoptotic proteins in a search for cancer
Samir Mitragotri was the winner of the 2015 Andreas Acrivos Award for Professional Progress in Chemical Engineering.
A startup in southern California is designing microbes that extend DNA beyond the natural A, T, G, and C components to include X and Y.
It sounds like something straight out of a science fiction movie: bacteria that feeds on human flesh.
Research suggests that flakes of graphene welded together into solid materials may have potential for use as bone implants.
Multidrug resistance (MDR) is one of main reasons chemotherapy drugs fail.
Forty healthy volunteers will undergo phase I clinical testing of a Zika DNA vaccine in a few weeks.
Biological engineer James Collins of MIT and a team of researchers have created a paper-based test that differentiates between Zika virus strains.
If you could eradicate the Aedes aegypti mosquito responsible for spreading the Zika virus in the Americas, would you? And should you? Those are some of the big questions being tossed about among biologists, ecologists, public health experts, and others today because the technology exists to bid farewell to the pesky mosquito.
The past few years have been full of stories about how a number of serious conditions could be treated or cured by introducing certain bacteria to the digestive system.
Yesterday an 18-month-old research group called Rubius was officially launched with the mission to genetically engineer red blood cells for dru
Zhenan Bao is the 2015 recipient of the Andreas Acrivos Award for Professional Progress in Chemical Engineering.
Samir Mitragotri of UC Santa Barbara's Chemical Engineering Department discusses new journal, Bioengineering & Translational Medicine, and winning Acrivos Award for Professional Progress.
JoAnn Lighty is currently the Division Director for Chemical, Bioengineering, Environmental,
The American Institute of Chemical Engineers (AIChE) and its Society for Biological Engineering (SBE), in partnership with John Wiley and Sons, will launch a new quarterly, peer-reviewed, online, o
Researchers at Sandia National Laboratories have created linkages of polymer nanotubes that resemble the structure of a nerve and are capable of transmitting electrical impulses.
Because detecting biological molecules for medical diagnostic work is an expensive process, Swiss researchers at EPFL set out to find a more econom
Pills and injections may soon be pushed to the side if the MIT chemical engineering team of Michael Cima and Robert Langer have their way.
This week, a group of chemists and biologists working at the University of California San Diego announced that they have designed and synthesized an artificial cell membrane capable of sustaining c
Just last week we wrote about antibiotic resistance and new rapid testing, and this week
The National Institute of Standards and Technology (NIST) has release the world’s first “yardstick” to help ensure the accuracy of human DNA sequencing.
Graphene strips were used to sequentially deliver two drugs to targeted areas of cancer cells.
SQZ Biotech, a company founded by a group of MIT chemical engineers, thinks it may have a very good solution to help battle diseases such as cancer and HIV.
Aaron C. Anselmo of University of California, Santa Barbara (UCSB), presents his work on nanoparticle drug delivery systems inspired by human blood cells in an AIChE poster session.
A group called the Global Alliance for Genomics and Health (known as the Global Alliance) wants to maximize the use of genetic
Google has announced that one of the special projects it's working on entails creating a wristband that will perform diagnostic tests on the wearer, such as looking for indicators of cancer and heart disease, among other ailments.
Some cancer patients are turning to mice that are grafted with tumor tissue and become living labs for individual patients.
Nancy Chang left her home in Taiwan at age 19 and set off for America to study. With the decision to study biology, she took the first step in a long journey that led to a highly successful career in biotechnology.
Researchers have successfully created a bioreactor that generates human platelets in vitro, potentially addressing blood transfusion needs worldwide.
New immunotherapy treatment uses genetics of patient's own tumor to fight cancer.
Researchers at Boston’s Brigham and Women’s Hospital (BWH) in Boston are making progress in manufacturing blood vessels through 3D bioprinting.
Recent years have brought massive changes in drug delivery, and biological engineers are at the forefront.
Unlike the Google Glass, Google's contact lens should not be scary to anyone. Developed as a blood glucose monitoring device, millions of diabetics could benefit from the lens.
Researchers have successfully created retinal cells that could ultimately be used to treat conditions such as macular degeneration.
Tiffany King has a great piece of advice for anyone looking to find success: have an end goal in mind.
The same plastic that is used to make many bottles can be transformed into a novel molecule that is highly effective at killing drug-resistant fungi.
Four upcoming webinars provide the opportunity to learn more about—and influence—the direction of soft-matter research programs funded by the U.S. Materials Genome Initiative.
Learn how one grad student in biological engineering has increased his professional reach and enriched his career as a volunteer.
